{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:21:06Z","timestamp":1783074066899,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Congenital Heart Disease"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ijcchd.2022.100328","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T06:53:09Z","timestamp":1643179989000},"page":"100328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Thromboembolic characteristics and role of anticoagulation in long-standing Fontan circulation"],"prefix":"10.1016","volume":"7","author":[{"given":"Mechthild","family":"Westhoff-Bleck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Klages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Zwadlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Sonnenschein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Thorben","family":"Sieweke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9341-117X","authenticated-orcid":false,"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Bertram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urte","family":"Grosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.ijcchd.2022.100328_bib1","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jacc.2015.07.065","article-title":"40-Year follow-up after the Fontan operation: long-term outcomes of 1,052 patients","volume":"66","author":"Pundi","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"Abstract Supplement","key":"10.1016\/j.ijcchd.2022.100328_bib2","article-title":"Thromboembolic complications in adults with longstanding Fontan circulation: time course, risk factors and role of anticoagulation","volume":"31","author":"Westhoff-Bleck","year":"2010","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ijcchd.2022.100328_bib3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0003-4975(02)03677-9","article-title":"Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches","volume":"74","author":"Seipelt","year":"2002","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.ijcchd.2022.100328_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jtcvs.2004.08.045","article-title":"Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary anastomosis","volume":"129","author":"Kaulitz","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.ijcchd.2022.100328_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.107.738559","article-title":"Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery","volume":"117","author":"Khairy","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcchd.2022.100328_bib6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/ejcts\/ezu145","article-title":"Prevalence and predictors of haemostatic complications in 412 Fontan patients: their relation to anticoagulation and haemodynamics","volume":"47","author":"Ohuchi","year":"2015","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"Issue 6","key":"10.1016\/j.ijcchd.2022.100328_bib7","first-page":"563","volume":"42","author":"Baumgartner","year":"2020","journal-title":"International Society for Adult Congenital Heart Disease (ISACHD)European Heart Journal"},{"key":"10.1016\/j.ijcchd.2022.100328_bib8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jacc.2012.08.1023","article-title":"Fontan Anticoagulation Study Group Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure","volume":"61","author":"McCrindle","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.ijcchd.2022.100328_bib9","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/heartjnl-2015-307930","article-title":"Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis","volume":"101","author":"Alsaied","year":"2015","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ijcchd.2022.100328_bib10","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1016\/j.ijcard.2013.06.058","article-title":"Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation","volume":"168","author":"Potter","year":"2013","journal-title":"Int J Cardiol"},{"issue":"4 Pt 1","key":"10.1016\/j.ijcchd.2022.100328_bib11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0022-5223(00)70010-9","article-title":"Hess J Intracardiac thrombus formation after the Fontan operation","volume":"119","author":"Balling","year":"2000","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"12","key":"10.1016\/j.ijcchd.2022.100328_bib12","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jacc.2016.06.056","article-title":"Thrombotic and embolic complications associated with atrial arrhythmia after Fontan operation: role of prophylactic therapy","volume":"68","author":"Egbe","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ijcchd.2022.100328_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001224","article-title":"Atrial arrhythmias and thromboembolic complications in adults post Fontan surgery","volume":"7","author":"Wan","year":"2020","journal-title":"Open Heart"},{"issue":"12","key":"10.1016\/j.ijcchd.2022.100328_bib14","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.cjca.2019.08.038","article-title":"Clinical importance of Fontan circuit thrombus in the adult population: significant association with increased risk of cardiovascular events","volume":"35","author":"Sathananthan","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ijcchd.2022.100328_bib15","unstructured":"Stout KK, Daniels CJ, Aboulhosn JA, et al. Guideline for the Management of Adults With Congenital Heart Disease. A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. https:\/\/www.ahajournals.org\/doi\/pdf\/10.1161\/CIR.0000000000000603."},{"issue":"6","key":"10.1016\/j.ijcchd.2022.100328_bib16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jacc.2011.01.061","article-title":"A multicenter, randomized trial comparing heparin\/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children","volume":"58","author":"Monagle","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcchd.2022.100328_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ahj.2016.09.014","article-title":"Prevalence and outcome of thrombotic and embolic complications in adults after Fontan operation","volume":"183","author":"Egbe","year":"2017","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.ijcchd.2022.100328_bib18","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/ejcts\/ezw159","article-title":"No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients","volume":"50","author":"Iyengar","year":"2016","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.ijcchd.2022.100328_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2017.10.047","article-title":"Fontan failure and death in contemporary Fontan circulation: analysis from the last two decades","author":"Kotani","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.ijcchd.2022.100328_bib20","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0022-5223(02)73605-2","article-title":"Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis","volume":"125","author":"Odegard","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ijcchd.2022.100328_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijcard.2014.11.219","article-title":"Aspirin resistance in adult patients after Fontan surgery","volume":"181","author":"Tomkiewicz-Pajak","year":"2015","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ijcchd.2022.100328_bib22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/heartjnl-2017-311838","article-title":"Histopathological abnormalities in the central arteries and veins of Fontan subjects","volume":"104","author":"Hays","year":"2018","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ijcchd.2022.100328_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2011.07.053","article-title":"Pathophysiology of chronic venous insufficiency in adults with a Fontan circulation (a pre-defined substudy of the CALF investigation)","volume":"165","author":"Bhatt","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ijcchd.2022.100328_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jacc.2010.02.048","article-title":"AARCC (alliance for adult research in congenital cardiology) investigators. The CALF (congenital heart disease in adults lower extremity systemic venous health in Fontan patients) study","volume":"56","author":"Valente","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcchd.2022.100328_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijcard.2018.05.039","article-title":"Venous congestion and pulmonary vascular function in Fontan circulation: implications for prognosis and treatment","volume":"271","author":"Egbe","year":"2018","journal-title":"Int J Cardiol"},{"issue":"21","key":"10.1016\/j.ijcchd.2022.100328_bib26","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"Brighton","year":"2012","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.ijcchd.2022.100328_bib27","first-page":"1959","article-title":"WARFASA investigators","volume":"366","author":"Beccatini","year":"2012","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.ijcchd.2022.100328_bib28","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1136\/heartjnl-2015-307514","article-title":"Prevalence of atrial tachyarrhythmia in adults after Fontan operation","volume":"101","author":"Quinton","year":"2015","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.ijcchd.2022.100328_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0735-1097(00)01141-4","article-title":"Outcomes of late atrial tachyarrhythmias in adults after the Fontan operation","volume":"37","author":"Ghai","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ijcchd.2022.100328_bib30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/europace\/eut333","article-title":"Atrial fibrillation patients do not benefit from acetylsalicylic acid","volume":"16","author":"Sj\u00e4lander","year":"2014","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.ijcchd.2022.100328_bib31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ijcard.2014.07.104","article-title":"Acquired von Willebrand syndrome in adult patients with congenital heart disease","volume":"176","author":"Waldow","year":"2014","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ijcchd.2022.100328_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11239-017-1499-8","article-title":"Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients","volume":"44","author":"Faircloth","year":"2017","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"10.1016\/j.ijcchd.2022.100328_bib33","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/europace\/euy054","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary","volume":"20","author":"Steffel","year":"2018","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.ijcchd.2022.100328_bib34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.amjcard.2015.10.062","article-title":"Usefulness of direct oral anticoagulants in adult congenital heart disease","volume":"117","author":"Pujol","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcchd.2022.100328_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/chd.12603","article-title":"Novel oral anticoagulant use in adult Fontan patients: a single center experience","author":"Georgekutty","year":"2018","journal-title":"Congenit Heart Dis"},{"issue":"4","key":"10.1016\/j.ijcchd.2022.100328_bib36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10557-017-6745-y","article-title":"Non vitamin K antagonist oral anticoagulants for ThromboEmbolic prevention in adult congenital heart disease (NOTE) investigators. Is initiating NOACs for atrial arrhythmias safe in adults with congenital heart disease?","volume":"31","author":"Yang","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ijcchd.2022.100328_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijcard.2017.12.038","article-title":"Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: implementation of guidelines","volume":"257","author":"Yang","year":"2018","journal-title":"Int J Cardiol"},{"issue":"43","key":"10.1016\/j.ijcchd.2022.100328_bib38","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1093\/eurheartj\/ehaa844","article-title":"Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients","volume":"41","author":"Freisinger","year":"2020","journal-title":"Eur Heart J"}],"container-title":["International Journal of Cardiology Congenital Heart Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666668522000118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666668522000118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T15:44:11Z","timestamp":1729179851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666668522000118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":38,"alternative-id":["S2666668522000118"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcchd.2022.100328","relation":{},"ISSN":["2666-6685"],"issn-type":[{"value":"2666-6685","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thromboembolic characteristics and role of anticoagulation in long-standing Fontan circulation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Congenital Heart Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcchd.2022.100328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100328"}}